{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:05Z","timestamp":1787003465893,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Patients with established rheumatoid arthritis (RA) and disease modifying treatments have lower nitric oxide (NO) levels in the alveolar compartment (C\n                    <jats:sub>A<\/jats:sub>\n                    NO) and in the airway wall (C\n                    <jats:sub>aw<\/jats:sub>\n                    NO), but also higher diffusion capacities for NO in the airways (D\n                    <jats:sub>aw<\/jats:sub>\n                    NO) compared to matched controls. The aim of the present study was to investigate the NO lung dynamics in patients with recent onset RA before and after immune suppression with methotrexate therapy. Patients with early RA and antibodies against anticitrullinated peptides (ACPA) were recruited. Measurement of exhaled NO and inflammatory markers in serum were performed. Clinical disease activity was evaluated with Disease Activity Score for 28 joints. Healthy individuals were used as matched controls. Data are presented as median (lower quartile, upper quartile) values. RA patients (n\u2009=\u200944) had lower exhaled NO (F\n                    <jats:sub>E<\/jats:sub>\n                    NO\n                    <jats:sub>50<\/jats:sub>\n                    ) 16 (10\u201324) ppb compared to controls 21 (15, 29) ppb, p\u2009=\u20090.013. In NO-dynamics, C\n                    <jats:sub>A<\/jats:sub>\n                    NO was lower in RA patients 1.6 (1.0, 2.2) ppb compared to the control subjects 2.3 (1.3, 3.1) ppb, p\u2009=\u20090.007. C\n                    <jats:sub>aw<\/jats:sub>\n                    NO was also lower in the RA patients 55 (24, 106) ppb compared to control subjects 124 (110, 170) ppb, p\u2009&lt;\u20090.001, but D\n                    <jats:sub>aw<\/jats:sub>\n                    NO was higher 17 (8, 30) mL\/s and 9 (5, 11) mL\/s respectively, p\u2009&lt;\u20090.001. Methotrexate treatment for three months reduced disease activity, but did not change the NO dynamics. In conclusion, the altered NO dynamics of the lung in ACPA-positive RA patients are already present in the early stages of the disease before any treatments and do not change after methotrexate therapy suggesting a role in the pathogenesis.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-10334-5","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T10:07:40Z","timestamp":1650449260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Exhaled nitric oxide in early rheumatoid arthritis and effects of methotrexate treatment"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-7116","authenticated-orcid":false,"given":"Tomas","family":"Weitoft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-0402","authenticated-orcid":false,"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-3226","authenticated-orcid":false,"given":"Johan","family":"R\u00f6nnelid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6392-6092","authenticated-orcid":false,"given":"Marieann","family":"H\u00f6gman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"issue":"8\u20139","key":"10334_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s000180050352","volume":"55","author":"JL Boucher","year":"1999","unstructured":"Boucher, J. L., Moali, C. & Tenu, J. P. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol. Life Sci. 55(8\u20139), 1015\u20131028 (1999).","journal-title":"Cell Mol. Life Sci."},{"issue":"9","key":"10334_CR2","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.93.06091368","volume":"6","author":"K Alving","year":"1993","unstructured":"Alving, K., Weitzberg, E. & Lundberg, J. M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J. 6(9), 1368\u20131370 (1993).","journal-title":"Eur. Respir. J."},{"key":"10334_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/rmed.2001.1204","volume":"96","author":"M H\u00f6gman","year":"2002","unstructured":"H\u00f6gman, M. et al. Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir. Med. 96, 24\u201330 (2002).","journal-title":"Respir. Med."},{"key":"10334_CR4","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s10067-020-05050-2","volume":"39","author":"G Damiani","year":"2020","unstructured":"Damiani, G. et al. Patients with psoriatic arthritis have higher levels of FENO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvement. Clin. Rheumatol. 39, 2981\u20132988 (2020).","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10334_CR5","first-page":"32","volume":"26","author":"KP Tiev","year":"2009","unstructured":"Tiev, K. P. et al. Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis. Sarcoidosis Vasc. Diffuse Lung Dis. 26(1), 32\u201338 (2009).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10334_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1034\/j.1399-3003.1999.13d07.x","volume":"13","author":"D Ludviksdottir","year":"1999","unstructured":"Ludviksdottir, D. et al. Increased nitric oxide in exhaled air in patients with Sj\u00f6gren\u2019s syndrome. Eur. Respir. J. 13, 739\u2013743 (1999).","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10334_CR7","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s10067-019-04536-y","volume":"38","author":"G Damiani","year":"2019","unstructured":"Damiani, G. et al. Malar rash is a predictor of subclinical airway inflammation in patients with systemic lupus erythematosus: a pilot study. Clin. Rheumatol. 38(9), 2541 (2019).","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10334_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/17476348.2017.1281746","volume":"11","author":"M H\u00f6gman","year":"2017","unstructured":"H\u00f6gman, M., Lehtim\u00e4ki, L. & Dinh-Xuan, A. T. Utilising exhaled nitric oxide information to enhance diagnosis and therapy of respiratory disease - current evidence for clinical practice and proposals to improve the methodology. Expert Rev. Respir. Med. 11(2), 101\u2013109 (2017).","journal-title":"Expert Rev. Respir. Med."},{"issue":"11","key":"10334_CR9","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1136\/ard.51.11.1219","volume":"51","author":"AJ Farrell","year":"1992","unstructured":"Farrell, A. J. et al. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51(11), 1219\u20131222 (1992).","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10334_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.rbr.2014.07.003","volume":"54","author":"AM Ali","year":"2014","unstructured":"Ali, A. M. et al. Higher nitric oxide levels are associated with disease activity in Egyptian rheumatoid arthritis patients. Rev. Bras. Reumatol. 54(6), 446\u2013451 (2014).","journal-title":"Rev. Bras. Reumatol."},{"issue":"9","key":"10334_CR11","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/rheumatology\/39.9.1004","volume":"39","author":"RJ van\u2019t Hof","year":"2000","unstructured":"van\u2019t Hof, R. J. et al. Nitric oxide is a mediator of apoptosis in the rheumatoid joint. Rheumatology (Oxford) 39(9), 1004\u20131008 (2000).","journal-title":"Rheumatology (Oxford)"},{"key":"10334_CR12","doi-asserted-by":"publisher","first-page":"8293921","DOI":"10.1155\/2020\/8293921","volume":"2020","author":"YY Chow","year":"2020","unstructured":"Chow, Y. Y. & Chin, K. Y. The role of inflammation in the pathogenesis of osteoarthritis. Med. Inflamm. 2020, 8293921 (2020).","journal-title":"Med. Inflamm."},{"issue":"11","key":"10334_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrrheum.2014.115","volume":"10","author":"AI Catrina","year":"2014","unstructured":"Catrina, A. I. et al. Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nat. Rev. Rheumatol. 10(11), 645\u2013653 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"10334_CR14","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Primers. 4, 18001 (2018).","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"6","key":"10334_CR15","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/art.34344","volume":"64","author":"MK Demoruelle","year":"2012","unstructured":"Demoruelle, M. K. et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: Early injury or initiating site of autoimmunity?. Arthritis Rheum. 64(6), 1756\u20131761 (2012).","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10334_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/art.41417","volume":"73","author":"KD Deane","year":"2021","unstructured":"Deane, K. D. & Holers, V. M. Rheumatoid arthritis: Pathogenesis, prediction and prevention\u2014An emerging paradigm shift. Arthritis Rheumatol. 73(2), 181\u2013193 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"10334_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2018.02.008","volume":"76","author":"A Thornadtsson","year":"2018","unstructured":"Thornadtsson, A. et al. Altered levels of exhaled nitric oxide in rheumatoid arthritis. Nitric Oxide 76, 1\u20135 (2018).","journal-title":"Nitric Oxide"},{"issue":"9","key":"10334_CR18","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62(9), 2569\u20132581 (2010).","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10334_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1475-097X.2008.00831.x","volume":"29","author":"M H\u00f6gman","year":"2009","unstructured":"H\u00f6gman, M. et al. Extended NO analysis in a healthy subgroup of a random sample from a Swedish population. Clin. Physiol. Funct. Imaging 29(1), 18\u201323 (2009).","journal-title":"Clin. Physiol. Funct. Imaging"},{"issue":"4","key":"10334_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/03009748809098795","volume":"17","author":"C Ekdahl","year":"1988","unstructured":"Ekdahl, C. et al. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand. J. Rheumatol. 17(4), 263\u2013271 (1988).","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10334_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo, M. L. et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38(1), 44\u201348 (1995).","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10334_CR22","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","volume":"171","author":"S American Thoracic","year":"2005","unstructured":"American Thoracic, S. & European, R. S. ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am. J. Respir. Crit. Care Med. 171(8), 912\u2013930 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10334_CR23","doi-asserted-by":"publisher","first-page":"17E4904","DOI":"10.1183\/13993003.00965-2016","volume":"49","author":"I Horvath","year":"2017","unstructured":"Horvath, I. et al. A European Respiratory Society technical standard: Exhaled biomarkers in lung disease. Eur. Respir. J 49(4), 17E4904 (2017).","journal-title":"Eur. Respir. J"},{"key":"10334_CR24","first-page":"551","volume":"21","author":"H Hedenstr\u00f6m","year":"1985","unstructured":"Hedenstr\u00f6m, H., Malmberg, P. & Agarwal, K. Reference values for lung function tests in female. Regression equations with smoking variables. Bull. Eur. Physiopathol. Respir. 21, 551\u2013557 (1985).","journal-title":"Bull. Eur. Physiopathol. Respir."},{"key":"10334_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/03009738609178670","volume":"91","author":"H Hedenstr\u00f6m","year":"1986","unstructured":"Hedenstr\u00f6m, H., Malmberg, P. & Fridriksson, H. V. Reference values for pulmonary function test in men: Regression equations which include tobacco smoking variables. Upsala J. Med. Sci. 91, 299\u2013310 (1986).","journal-title":"Upsala J. Med. Sci."},{"key":"10334_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2008.096487","volume":"69","author":"D Sugiyama","year":"2010","unstructured":"Sugiyama, D. et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: A meta-analysis of observational studies. Ann. Rheum. Dis. 69, 70\u201381 (2010).","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10334_CR27","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/ard.2009.114694","volume":"69","author":"P Stolt","year":"2010","unstructured":"Stolt, P. et al. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann. Rheum. Dis. 69(6), 1072\u20131076 (2010).","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10334_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/annrheumdis-2015-208278","volume":"75","author":"CL Too","year":"2016","unstructured":"Too, C. L. et al. Occupational exposure to textile dust increases the risk of rheumatoid arthritis: Results from a Malaysian population-based case-control study. Ann. Rheum. Dis. 75(6), 997\u20131002 (2016).","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10334_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/cs1030015","volume":"103","author":"M H\u00f6gman","year":"2002","unstructured":"H\u00f6gman, M. et al. Increased nitric oxide elimination from the airways after smoking cessation. Clin. Sci. (Lond.) 103(1), 15\u201319 (2002).","journal-title":"Clin. Sci. (Lond.)"},{"issue":"2","key":"10334_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1183\/09031936.06.00113705","volume":"28","author":"A Malinovschi","year":"2006","unstructured":"Malinovschi, A. et al. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur. Respir. J. 28(2), 339\u2013345 (2006).","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10334_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/hr.2015.130","volume":"39","author":"BA Taylor","year":"2016","unstructured":"Taylor, B. A. et al. The impact of tetrahydrobiopterin administration on endothelial function before and after smoking cessation in chronic smokers. Hypertens Res. 39(3), 144\u2013150 (2016).","journal-title":"Hypertens Res."},{"issue":"1","key":"10334_CR32","doi-asserted-by":"publisher","first-page":"016008","DOI":"10.1088\/1752-7163\/abc054","volume":"15","author":"T Karvonen","year":"2020","unstructured":"Karvonen, T. et al. Onset of action of inhaled glucocorticoids on bronchial and alveolar nitric oxide output. J. Breath Res. 15(1), 016008 (2020).","journal-title":"J. Breath Res."},{"key":"10334_CR33","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1164\/ajrccm.161.4.9903111","volume":"161","author":"PE Silkoff","year":"2000","unstructured":"Silkoff, P. E. et al. Airway nitric oxide diffusion in asthma. Role in pulmonary function and bronchial responsiveness. Am. J. Respir. Crit. Care Med. 161, 1218\u20131228 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10334_CR34","first-page":"81","volume":"37","author":"R Bordy","year":"2019","unstructured":"Bordy, R. et al. Methotrexate did not improve endothelial function in rheumatoid arthritis: A study in rats with adjuvant-induced arthritis. Clin. Exp. Rheumatol. 37(1), 81\u201388 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"10334_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/ard.22.4.269","volume":"22","author":"E Nettelbladt","year":"1963","unstructured":"Nettelbladt, E. & Sandell, B. M. Amino-acid content of serum in rheumatoid arthritis. Ann. Rheum. Dis. 22, 269\u2013272 (1963).","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10334_CR36","first-page":"358","volume":"17","author":"LW Huang","year":"2001","unstructured":"Huang, L. W. et al. Arginase levels are increased in patients with rheumatoid arthritis. Kaohsiung J. Med. Sci. 17(7), 358\u2013363 (2001).","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"1","key":"10334_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13075-018-1616-x","volume":"20","author":"UM Chandrasekharan","year":"2018","unstructured":"Chandrasekharan, U. M. et al. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis. Arthritis Res. Ther. 20(1), 123 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"10334_CR38","doi-asserted-by":"publisher","first-page":"318087","DOI":"10.1155\/2012\/318087","volume":"2012","author":"J Vitecek","year":"2012","unstructured":"Vitecek, J. et al. Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges. Med. Inflamm. 2012, 318087 (2012).","journal-title":"Med. Inflamm."},{"key":"10334_CR39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1164\/ajrccm.149.2.7508323","volume":"149","author":"B Gaston","year":"1994","unstructured":"Gaston, B. et al. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149, 538\u2013551 (1994).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1\u20133","key":"10334_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejphar.2005.12.057","volume":"533","author":"FL Ricciardolo","year":"2006","unstructured":"Ricciardolo, F. L. et al. Reactive nitrogen species in the respiratory tract. Eur. J. Pharmacol. 533(1\u20133), 240\u2013252 (2006).","journal-title":"Eur. J. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10334-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10334-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10334-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T21:03:04Z","timestamp":1669323784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10334-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10334"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-10334-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"6 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6489"}}